PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024
INCLINE VILLAGE, Nev., Aug. 28, 2020 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021 (the "2021 Notes") and in December 2024 (the "2024 Notes" and together with the 2021…
PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024
INCLINE VILLAGE, Nev., Aug. 28, 2020 |PRNewswire| -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021 (the "2021 Notes") and in December 2024 (the "2024 Notes" and together with the 2021…